Continuation of smoking after treatment of laryngeal cancer: An independent prognostic factor?

ORL

Volumn 74, Issue 5, 2013, Pages 250-254

  Kikidis, Dimitrios ^a   Vlastarakos, Petros V ^b   Manolopoulos, Leonidas ^a   Yiotakis, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b LISTER HOSPITAL   (United Kingdom)

Author keywords

Laryngeal cancer; Recurrence; Smoking; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SMOKING CESSATION; SURVIVAL RATE;

ADULT; AGED; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL RATE;

EID: 84867460056     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000342685     Document Type: Article

References (32)

1. Hashibe M, Brennan P, Benhamou S, et al: Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99:777-789. (Pubitemid 47073524)
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 1993;328:184-194.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
4. Cattaruzza MS, Maisonneuve P, Boyle P: Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 1996;32B:293-305.
5. Brownan GP, Wong G, Hodson I, et al: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Eng J Med 1993;328:159-163. (Pubitemid 23021501)
6. Stevens MH, Gardner JW, Parkin JL, et al: Head and neck cancer survival and life-style change. Arch Otolaryngol 1983;109:476-479.
7. Silverman S, Gorsky M, Greenspan D: Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc 1983;106:33-35.
8. Warnakulasuriya KA, Robinson D, Evans H: Multiple primary tumours following head and neck cancer in southern England during 1961-98. J Oral Pathol Med 2003;32:443-449. (Pubitemid 37039917)
9. Lin HW, Bhattacharyya N: Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope 2008;118:1003-1013. (Pubitemid 351787270)
10. Day GL, Blot W, Shore R, et al: Second cancers following oral and pharyngeal cancer: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-137. (Pubitemid 24040152)
11. Do KA, Johnson MM, Doherty DA, Wu XF: Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003;14:131-138. (Pubitemid 36539519)
12. Vermorken B, Remenar E, van Herpen C, et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. New Engl J Med 2007;357:1695-1704. (Pubitemid 350005151)
13. American Cancer Society: Cancer Facts and Figures 2008. Atlanta, American Cancer Society, 2008, USA.
14. Vassileiou A, Vlastarakos PV, Kandiloros D, et al: Laryngeal cancer: smoking is not the only risk factor. B-ENT 2012, in press.
15. Reis L, Reichman M, Lewis D, et al: Cancer survival and incidence from the surveillance, epidemiology and end results (SEER) program. Oncologist 2003;8:541-552. (Pubitemid 37467370)
16. Kokkevi A, Terzidou M, Politikou K, Stefanis C: Substance use among high school students in Greece: outburst of illicit drug use in a society under change. Drug Alcohol Depend 2000;58:181-188.
17. Pitsavos C, Panagiotakos D, Chrysohoou C, Stefanadis C: Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 2003;3:32.
18. Steptoe A, Wardle J, Cui W, et al: Trends in smoking, diet, physical exercise, and attitudes toward health in European university students from 13 countries, 1990-2000. Prev Med 2002;35:97-104.
19. Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-1435. (Pubitemid 47463055)
20. Chatzimichalis M, Xenellis J, Tzagaroulakis A, et al: GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population. J Laryngol Otol 2010;124:318-323.
21. Rohrer J, Wuertz BR, Ondrey F: Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic factors in aerodigestive cells. Laryngoscope 2010;120:1609-1613.
22. Brachman DG, Graves D, Vokes E, et al: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52:4832-4836.
23. Gillison L, Shah KV: Human papillomavirus associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001;13:183-188. (Pubitemid 32433975)
24. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K: CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 2005;574:112-123. (Pubitemid 40725973)
25. Culjkovic B, Borden KL: Understanding and targeting the eukaryotic translation initiation factor eIF4E in head and neck cancer. J Oncol 2009:981679.
26. Li G, Sturgis EM: The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep 2006;8:130-139.
27. Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-1435. (Pubitemid 47463055)
28. Gillison ML: Human papillomavirus associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31:744-754. (Pubitemid 39602680)
29. Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski B: Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 2003;56:399-412. (Pubitemid 36542899)
30. Nyström L, Rutqvist LE, Wall S, et al: Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 2002;359:909-919. (Pubitemid 34246378)
31. Zauber AG: Cost-effectiveness of colonoscopy. Gastrointest Endosc Clin N Am 2010;20:751-770.
32. Cruz GD, Le Gros RZ, Ostroff JS, et al: Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program. J Am Dent Assoc 2002;133:1064-1071.